Systematic reductions in NAFLD-related indicators, including TG and total cholesterol (TC) levels, AST and ALT activities, lipid droplet size, inflammatory infiltration, and fibrosis, were observed in shUSP14 mice compared to the HFD-shNC group (Fig. 3E–K). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.